Originally, Curavisc® was developed and manufactured by Curasan AG, a German company specializing in biomaterials for bone and tissue regeneration. However, in 2021, Bioventus acquired the rights to Curavisc® and other viscosupplementation products from Curasan AG.

Bioventus LLC is a U.S.-based global company that develops, manufactures, and markets medical products focused on orthobiologics, joint preservation, and osteoarthritis pain relief. Their portfolio includes devices and therapies for bone healing, osteoarthritis management, and other orthopedic conditions.